{"log_id": 8402836229298224319, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.000412, "average": 0.991512, "min": 0.894931}, "location": {"width": 817, "top": 109, "height": 71, "left": 196}, "words": "建议起始剂量为每次0.5mg、每日2次,剂量可根据个体需要进行调整。剂量增加的幅"}, {"probability": {"variance": 0.01612, "average": 0.933666, "min": 0.450512}, "location": {"width": 551, "top": 168, "height": 58, "left": 142}, "words": "度可为每次0.5mg、每日2次,直至一次1-2mg每日2次"}, {"probability": {"variance": 0, "average": 0.999608, "min": 0.998844}, "location": {"width": 189, "top": 310, "height": 36, "left": 154}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.002052, "average": 0.98502, "min": 0.775689}, "location": {"width": 785, "top": 323, "height": 70, "left": 147}, "words": "1.鉴于本品对中枢神经系统的作用,在与其它作用于中枢系统的药物合用时应慎重"}, {"probability": {"variance": 0.006977, "average": 0.97219, "min": 0.603608}, "location": {"width": 487, "top": 382, "height": 53, "left": 150}, "words": "2.本品可拮抗左旋多巴及其它多巴胺激动剂的作用"}, {"probability": {"variance": 0.011946, "average": 0.966205, "min": 0.527529}, "location": {"width": 590, "top": 419, "height": 59, "left": 151}, "words": "3.上市后合用抗高血压药物时,曾观察到有临床意义的低血压"}, {"probability": {"variance": 0.001812, "average": 0.981216, "min": 0.83318}, "location": {"width": 437, "top": 469, "height": 52, "left": 152}, "words": "4.与已知会延长QT间期的药物合用时应谨慎"}, {"probability": {"variance": 0.009516, "average": 0.9728, "min": 0.489338}, "location": {"width": 872, "top": 490, "height": 72, "left": 155}, "words": "5.卡马西平及其它CYP3A4肝酶诱导剂会降低本品活性成份的租浆浓度,开始或停山使用卡"}, {"probability": {"variance": 0.000139, "average": 0.994474, "min": 0.946899}, "location": {"width": 583, "top": 544, "height": 60, "left": 192}, "words": "马西平或其它CYP3A4肝诱酶时,应重新确定使用本品的剂量"}, {"probability": {"variance": 0.000498, "average": 0.986457, "min": 0.894359}, "location": {"width": 837, "top": 576, "height": 68, "left": 192}, "words": "氟西汀和帕罗西汀(CYP2D6抑制剂)可增加本品的血药浓度,但对其抗精神病活性成份"}, {"probability": {"variance": 0.003455, "average": 0.978076, "min": 0.665195}, "location": {"width": 834, "top": 617, "height": 70, "left": 197}, "words": "血药浓度的影响较小。当开始或停止与氟西汀或帕罗西汀合用时,医生应重新确定本品的"}, {"probability": {"variance": 0.01346, "average": 0.948807, "min": 0.560686}, "location": {"width": 871, "top": 703, "height": 71, "left": 165}, "words": "7.托吡酯略微降低利培酮的生物利用度,对本品中的抗精神病活性成份无影响。因此,该相"}, {"probability": {"variance": 1e-06, "average": 0.999172, "min": 0.99841}, "location": {"width": 43, "top": 703, "height": 25, "left": 199}, "words": "剂量"}, {"probability": {"variance": 6e-06, "average": 0.998484, "min": 0.991209}, "location": {"width": 284, "top": 772, "height": 42, "left": 199}, "words": "互作用基本上不具有临床意义"}, {"probability": {"variance": 0.013073, "average": 0.962334, "min": 0.49303}, "location": {"width": 837, "top": 786, "height": 69, "left": 201}, "words": "酚噻嗪类抗精神病药、三环抗抑郁药和一些β一阻断剂会培加本品的血药浓度,但不增加"}, {"probability": {"variance": 0.00975, "average": 0.969918, "min": 0.495194}, "location": {"width": 837, "top": 827, "height": 71, "left": 204}, "words": "其抗精神病活性成份的血药浓度。阿米替林不影响利培酮或其抗精神病活性成份的药代动"}, {"probability": {"variance": 0.018445, "average": 0.955026, "min": 0.364912}, "location": {"width": 450, "top": 889, "height": 52, "left": 206}, "words": "力学参数。西咪替丁和雷尼替丁可增加利培的"}, {"probability": {"variance": 9.2e-05, "average": 0.996387, "min": 0.959566}, "location": {"width": 344, "top": 872, "height": 42, "left": 698}, "words": "利用度,但对其抗精神病活性成份的"}, {"probability": {"variance": 0.016912, "average": 0.940871, "min": 0.470983}, "location": {"width": 835, "top": 909, "height": 78, "left": 209}, "words": "影响很小。红霉素(CYP3A4抑制剂)不铜或共抗精神病活性成份的药代动力学"}, {"probability": {"variance": 0.003185, "average": 0.983443, "min": 0.652355}, "location": {"width": 837, "top": 952, "height": 76, "left": 208}, "words": "参数。胆碱酯酶抑制剂加兰他敏和多派齐对利培酮或其抗精神病活性成份的药代动力学"}, {"probability": {"variance": 0.004711, "average": 0.951702, "min": 0.827476}, "location": {"width": 153, "top": 1033, "height": 34, "left": 211}, "words": "参数无显著影响"}, {"probability": {"variance": 0.013414, "average": 0.94258, "min": 0.502934}, "location": {"width": 823, "top": 1039, "height": 75, "left": 178}, "words": "9.当和其它高度蛋白结合的药物一起服用不海在有临坏意义的血浆蛋白的相互置换"}, {"probability": {"variance": 0.017847, "average": 0.949135, "min": 0.377731}, "location": {"width": 668, "top": 1090, "height": 63, "left": 186}, "words": "0.本品对锂、丙戊酸钠、地离辛或托吡的药动学参数显著影响"}, {"probability": {"variance": 0.003102, "average": 0.976331, "min": 0.763749}, "location": {"width": 730, "top": 1130, "height": 67, "left": 187}, "words": "11.有关老年痴呆患者合用呋塞米治疗死亡率增加的内容参见【注意事项】部分"}, {"probability": {"variance": 0.00047, "average": 0.992206, "min": 0.920638}, "location": {"width": 248, "top": 1197, "height": 42, "left": 187}, "words": "2.食物不影响本品的吸收"}, {"probability": {"variance": 2e-06, "average": 0.998939, "min": 0.996378}, "location": {"width": 124, "top": 1286, "height": 30, "left": 195}, "words": "【药物过量"}, {"probability": {"variance": 0.008286, "average": 0.968351, "min": 0.599284}, "location": {"width": 577, "top": 1301, "height": 58, "left": 245}, "words": "出现急性过量症状时,应考虑是否有其它药物合用引起的因素"}, {"probability": {"variance": 0.009516, "average": 0.971567, "min": 0.424656}, "location": {"width": 815, "top": 1330, "height": 70, "left": 248}, "words": "一般来说,所报道的过量时的症状和体征均为其药理作用的延伸所致,包括嗜和镇"}, {"probability": {"variance": 0.002529, "average": 0.982994, "min": 0.747062}, "location": {"width": 851, "top": 1372, "height": 72, "left": 192}, "words": "静、心动过速和低血压、以及锥体外系症状。药物过量时,曾有QT期延长和癫痫的报告"}, {"probability": {"variance": 0.00029, "average": 0.994605, "min": 0.910746}, "location": {"width": 576, "top": 1427, "height": 59, "left": 194}, "words": "过量的本品合用帕罗西汀时,曾有扭转型室性心动过速的报告"}, {"probability": {"variance": 0.039305, "average": 0.79272, "min": 0.594465}, "location": {"width": 61, "top": 1520, "height": 23, "left": 1000}, "words": " Page 13"}, {"probability": {"variance": 0.035975, "average": 0.828773, "min": 0.421709}, "location": {"width": 201, "top": 1554, "height": 29, "left": 176}, "words": " CCDS A地:07Jan08"}, {"probability": {"variance": 0.000331, "average": 0.973299, "min": 0.955099}, "location": {"width": 39, "top": 1586, "height": 19, "left": 203}, "words": " of 16"}], "language": 3}